Where does CHO Pharma, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CHO Pharma, Inc. ranks #31,201 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CHO Pharma, Inc. hold?

CHO Pharma, Inc. holds 8 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is CHO Pharma, Inc.'s Innovation Score?

CHO Pharma, Inc. has an Innovation Score of 31.8 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CHO Pharma, Inc. focus on?

CHO Pharma, Inc.'s top technology area is C07K (Peptides) with 8 patents. Grants appear in 7 CPC subclasses total.

Is CHO Pharma, Inc.'s patent grant rate increasing or decreasing?

CHO Pharma, Inc.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for CHO Pharma, Inc.'s patents?

CHO Pharma, Inc.'s patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CHO Pharma, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CHO Pharma, Inc.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CHO ranks #31,201 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#31,201
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.8/100): 13.6
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31201 · Foreign Corporation #31,201 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,201/49,997
PHOTO-FINISH China National Rice…
CPC-NARROW C07K · 7 areas
INNOV-THIN 31.8/100
CLAIMS-RICH 13.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: China National Rice Research Institute (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
CHO Pharma · this assignee

32
Clairson · near

32
ZEN Design Solutions · near

32
Apparatus · near

32
Imaging Services · near

32
3D Lighting… · lowest

7

What this shows CHO's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where CHO's grants concentrate

CHO Pharma, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2018. By volume, CHO sits between China National Rice Research Institute and Chun Kuang Optics Corp..

CHO's three-year grant acceleration

CHO Pharma, Inc. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

China National Ri…

8
China Resources M…

8
Chinese Academy O…

8
Chiome Bioscience

8
CHR MAYR + KG

8
Christiana Care H…

8
Chulalongkorn Uni…

8
Chun Kuang Optics

8
CHO Pharma ◀

8

What this shows CHO holds 8 patents at rank #31,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CHO

By rank, the assignees closest to #31,160 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in CHO's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CHO, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Clairson, Inc. 32 ZEN Design Solutions Limited 32 Electronic Imaging Services, Inc. 32 Apparatus LLC 32

CHO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

CHO Pharma, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	12.5%
2019	1	12.5%
2020	1	12.5%
2021	1	12.5%
2023	2	25.0%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does CHO Pharma, Inc. patent most?

C07K - Peptides 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C12Y - Enzymes 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#31,201

of 49,997 tracked assignees

Innovation Score

31.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CHO Pharma, Inc.'s patent record in context - here's where to go next.

CHO Pharma, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #31,201 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CHO Pharma, Inc. against China National Rice Research Institute, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.